Featured Stories

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Retailers in Suffolk County, New York, Have 90 Days to Display Warning Signs About Liquid Nicotine

A new law gives stores in Suffolk County, New York, 90 days to post warnings about the dangers of the liquid nicotine found in e-cigarettes.

Suffolk County Executive Steve Bellone signed the law on Monday. The new signs, which must be placed “in a conspicuous place at the register,” warn that liquid nicotine can be fatal and addictive. The move was spurred, in part, by the death of an 18-month-old child last year, and increased calls to poison control centers, according to Newsday. Continue reading

Posted in Toxic Substances |

Class I Recall Issued for Amy’s Kitchen Products Nationwide

A potential health risk has prompted Amy’s Kitchen, Inc. to voluntarily recall over 73,000 cases of products containing organic spinach nationwide. According to a recall alert issued on March 25th, one of Amy’s organic spinach suppliers may have received organic spinach with the possible presence of Listeria monocytogenes.

In healthy individuals, this organism may only trigger short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Young children, frail, or elderly people, however, are at risk for serious and sometimes fatal infections. In pregnant women, listeria infections may result in miscarriages and still births. Continue reading

Posted in Food Poisoning, Listeria |

15 Cases to be Selected as Eligible for Second Trial in Mirena MDL

A recent court order indicates that 15 cases will be selected as eligible for potential inclusion in the Second Disposition Pool of the Mirena IUD multidistrict litigation (MDL). According to the order, the plaintiffs’ and the defendants’ parties will select five cases each and another five will be selected at random from a full list of filed lawsuits. Plaintiffs in the litigation allege that the contraceptive device caused serious injuries and that Bayer HealthCare Pharmaceuticals Inc. failed to warn about the risks. In particular, a number of lawsuits allege that the device migrated from its original position and perforated through the uterine wall. In some cases, the IUD has allegedly embedded itself in other parts of the body.

Parker Waichman LLP, a national personal injury law firm, represents a number of women in the Mirena IUD litigation. The firm has also had an active leadership role; Matthew J. McCauley, Senior Litigation Counsel at the firm, has been appointed Co-Lead Counsel in the MDL. Continue reading

Posted in Defective Medical Devices, Legal News, Mirena IUD, Pharmaceuticals |

Former JCPenney Employee Files Whistleblower Lawsuit

Former JCPenney Employee Files Whistleblower Lawsuit

Former JCPenney Employee Files Whistleblower Lawsuit

A former part-time JCPenney employee has filed a lawsuit claiming retaliation after he reported the retailer was overcharging customers.

The fired employee has filed a claim against the company under Florida’s Private Whistleblower Act, Fortune reports. Former CEO Ron Johnson could be required to give a deposition. Continue reading

Posted in Legal News, Whistleblower | Tagged , , , , |

Zimmer Recalls Knee Replacement Device Following Increased Reports of Loosening

Zimmer Recalls Knee Replacement Device

Zimmer Recalls Knee Replacement Device

Medical device maker Zimmer, Inc. has initiated a voluntary recall of nearly 12,000 Persona Trabecular Metal Tibial knee replacement devices in response to increased complaints of loosening of the device.

The recall covers the Persona Trabecular Metal Tibial Plate/Persona TM Tibia-Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer, all lots land sizes, left and right. Research has shown that radiolucent lines (seen on x-rays), which show the gap between the cement and the device component, can be associated with early failure of the device. Some recipients have needed revision surgery to replace the defective component. Continue reading

Posted in Defective Medical Devices, Legal News | Tagged , , , , |

Regulatory Loophole Can Allow Unsafe Devices Onto Market

Regulatory Loophole Can Allow Unsafe Devices Onto Market

Regulatory Loophole Can Allow Unsafe Devices Onto Market

Data from the U.S. Food and Drug Administration (FDA) shows that there are over 100,000 medical devices on the market. Unfortunately, not all of them are safe. In fact, agency data indicates that between 13 and 75 devices are recalled in the United States every day. Motley Fool reports that a regulatory loophole, which allows devices to be sold and implanted into patients without clinical testing, may be a major contributing factor to these statistics.

Manufacturers can submit certain devices for 510(k) approval; this process can allow a device to be sold on the market without clinical testing for safety or efficacy so long as the FDA finds that the product is “substantially equivalent” to an older product. Only Class I and Class II devices are eligible for 510(k) clearance. Class III “high-risk” devices must go through the more stringent premarket approval. Continue reading

Posted in Health Concerns, Legal News, Product Recalls | Tagged , , , , |

Potential Cases to be Selected for Second Mirena IUD Trial

Potential Cases to be Selected for Second Mirena IUD Trial

Potential Cases to be Selected for Second Mirena IUD Trial


A recent court order has directed the parties to select seven cases that may be included in the second Mirena intrauterine device (IUD) trial.

According to a court order filed on March 17, 2015, each side must select seven cases for potential inclusion in the Second Disposition Pool. The case is In Re: Mirena Litigation, Case No. 297 in the Superior Court of New Jersey Law Division: Bergen County. Raymond C. Silverman, partner at Parker Waichman LLP, has been appointed co-lead counsel in the litigation. Continue reading

Posted in Defective Medical Devices, Mirena IUD | Tagged , , , , |

Antipsychotic Medications Linked to Increased Risk of Early Death in Dementia Patients

Antipsychotic Meds Linked to Death in Dementia Patients

Antipsychotic Meds Linked to Death in Dementia Patients


Antipsychotic medications are sometimes used to treat aggressive or violent behavior in patients with dementia, but new research suggests that health care professionals should consider the risks closely before prescribing them. According to study published in JAMA Psychiatry, antipsychotic medications can increase the risk of early death in patients with dementia, including those with Alzheimer’s Disease. The U.S. Food and Drug Administration (FDA) already warns that antipsychotic drugs can have serious side effects in patients with dementia. The findings from this study support the practice of not using these drugs in dementia patients.

Using medical records from over 91,000 veterans over the age of 65, researchers from the University of Michigan’s Medical School and VA Center for Clinical Management Research compared mortality death rates between patients taking antipsychotic drugs for dementia to those who did not. The study found a 3.8 percent increased risk of death in patients taking haloperidol compared to those who did not take any antipsychotic medications. There was a 2.5 percent increased risk of death in patients taking olanzapine. Continue reading

Posted in Legal News | Tagged , , , , , |

Kraft Foods Recalls Macaroni & Cheese Dinner Due to Possible Metal Pieces

Kraft Foods Recalls Macaroni & Cheese Dinner

Kraft Foods Recalls Macaroni & Cheese Dinner


Kraft Foods Group has voluntarily recalled approximately 242,000 cases of Original flavor Kraft Macaroni & Cheese Dinner because some boxes may contain small pieces of metal.

The recall is limited to the 7.25-oz. size of the Original flavor with “Best When Used By” dates of September 18, 2015 through October 11, 2015, with the code “C2” directly below the date on each individual box. The “C2” refers to the production line on which the affected product was made. Continue reading

Posted in Product Recalls, Recalled Medical Devices | Tagged , , , , |

Stryker Hip Settlement Enrollment Deadline Extended

Stryker Hip Settlement Enrollment Deadline Extended

Stryker Hip Settlement Enrollment Deadline Extended

The deadline for hip implant recipients to enroll in the Stryker Orthopaedics Rejuvenate Hip System settlement has been extended to March 30, 2015. Patients who received a recalled ABG II Modular Hip System or Rejuvenate Modular Hip System still have time to register with the settlement.

In June 2012, Stryker voluntarily recalled the ABG II and Rejuvenate Modular Hip Systems because of a high early failure rate and increased risks of metallosis. In November 2014, Stryker announced it had set aside $1.45 billion to compensate patients who received one of its recalled hip devices. Patients who had one hip implant removed prior to November 3, 2014 are eligible for $300,000; patients who had both hips implanted and removed will receive $600,000. Patients with more serious injuries or who required multiple surgeries could receive more than the base amount. The settlement also includes implant patients not able to have the hip(s) removed because a doctor deemed them unable to undergo surgery. Continue reading

Posted in Defective Medical Devices, Health Concerns, Metal Hip Implants, Recalled Medical Devices | Tagged , , , , |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.